In castration-resistant prostate cancer cells, nelfinavir did not activate caspase-3 at low doses; however, in combination with docetaxel and curcumin, caspase-3 was activated, which resulted in DNA fragmentation and cleavage of PARP [46]. Here, CASP3 is linked to prostate cancer.